How Much Did BASi Raise?
Funding & Key Investors

BASi has secured a significant enterprise-level funding round, with the total funding amount reaching $15.2M. The company recently announced a major strategic investment of $150K, underscoring its continued growth and market position. This latest financing event follows a series of previous capital infusions, indicating a robust trajectory for the organization.

What is BASi?

BASi
Healthcare ServicesMedical Laboratories & Imaging Centers

BASi, formerly known as Northwest Laboratory, is a comprehensive diagnostic and pathology services provider. The company offers a wide array of laboratory testing, including histology, immunohistochemistry, hematology, coagulation, chemistry, microbiology, women's health, and molecular testing. With state-of-the-art expertise and technology, BASi serves medical organizations across 37 states and provides pathology services to numerous hospitals and outpatient clinics. Their integrated approach, including a full histology laboratory operating round-the-clock and direct interfacing with electronic medical records systems, positions them as a trusted national healthcare partner. The company's commitment to precision and expert consultation, often in collaboration with its sister company NW Pathology (NWP), ensures high-quality patient care.

How much funding has BASi raised?

BASi has raised a total of $15.2M across 3 funding rounds:

1997

Stock Offering

$10M

2020

Debt

$5M

2024

Debt

$150K

Stock Issuance/Offering (1997): $10M, investors not publicly disclosed

Debt (2020): $5M led by PPP

Debt (2024): $150K supported by BayFirst National Bank

Key Investors in BASi

BayFirst National Bank

BayFirst National Bank is a financial institution that has provided debt financing to BASi, indicating a role in supporting the company's operational or expansionary capital needs.

PPP

Public-Private Partnership

What's next for BASi?

The recent major strategic investment of $150K signals a pivotal phase for BASi, likely focused on scaling operations, expanding service offerings, or enhancing technological capabilities. Given the enterprise-level nature of its total funding, BASi appears to be in a mature growth stage, potentially preparing for further market penetration or strategic acquisitions. This capital infusion will be critical in solidifying its competitive advantage in the diagnostic and pathology sector, enabling the company to further innovate and meet the evolving demands of healthcare providers and patients nationwide.

See full BASi company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Healthcare Services industry

Healthcare ServicesMedical Laboratories & Imaging Centers
Elderly Care ServicesHealthcare Services
Elderly Care ServicesHealthcare ServicesEducationTraining
Elderly Care ServicesHealthcare Services

Frequently Asked Questions Regarding BASi Financial Insights

What are the most recent funding rounds that BASi has completed, and what were the funding rounds?
BASi has recently completed 3 funding rounds: Debt on Dec 31, 2024, Debt on Apr 13, 2020, Stock Offering on Nov 24, 1997.
What is the total amount of funding BASi has raised to date?
BASi has raised a total of $15.2M in funding to date.
How many funding rounds has BASi completed?
BASi has completed 3 funding rounds.
How much funding did BASi raise in its most recent funding round?
BASi raised $150K in its most recent funding round.
Who are the lead investors in BASi's latest funding round?
The lead investor in BASi's latest funding round was BayFirst National Bank. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in BASi's history?
The largest funding round in BASi's history was $10M.
See more information about BASi